Facilitating effect of the hypnotically altered state of consciousness on decision-making in a situation modeling real-lifeEUROPEAN PSYCHIATRYIF6.72024-08-270OAAI
Characteristics of cognitive impulsivity in alcohol use and gambling disorder: a meta-analysis on decision making assessed with the Iowa gambling taskEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72017-10-010PREAI
Neuropsychological correlates of as-needed pharmacotherapy in alcohol dependence: double-blind placebo control study with the opioid antagonist nalmefeneEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72017-10-010PREAI
Association Analyses of Reln Rs4298437 and Rs6943822 Polymorphisms with Alzheimer's DiseaseEUROPEAN PSYCHIATRYIF6.72015-03-010PREAI
Examining mental animation with a dual-task paradigm in schizophreniaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72014-10-010PREAI
Psychological characteristics of psoriasis patients and their role in stress perceptionJOURNAL OF PSYCHOSOMATIC RESEARCHIF3.32014-06-010PREAI
The role of the dopamine beta-hydroxylase gene polymorphism in Alzheimer's diseaseEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72011-09-010PREAI
PLA2G4A and PTGS2 gene polymorphisms in schizophreniaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72011-04-010PREAI
No association between promoter polymorphism of the MAOA gene and Alzheimer's diseaseEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72011-04-010PREAI
Electrophysiological measures and clinical scales in schizophrenia and bipolar disorderEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72010-08-010PREAI
The role of sigma-1 receptor polymorphism in the pathogenesis of Alzheimer's disease: preliminary resultsEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72010-08-010PREAI
Adequacy of decision making is not associated with long-term abstinence in alcohol addictionEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72010-08-010PREAI
Alzheimer's disease risk and polymorphisms of the DHCR24 geneEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72010-08-010PREAI
Mismatch negativity and executive functions in schizophrenia and bipolar disorderEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72010-03-010PREAI
Electrophysiological measures in schizophrenia and bipolar disorderEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72009-09-010PREAI
The kinurenine pathway gene polymorphisms of the tryptophan metabolism do not play a role in Alzheimer's diseaseEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72009-05-011PREAI
Gamma band response during auditory information processing in schizophreniaEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72009-03-011PRE
Brain-derived neurotrophic factor and dopamine D3 receptor polymorphisms in schizophrenia and therapeutic responseEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72009-03-011PREAI
Epistasis of butyrylcholinesterase wt/wt and APOE e4 state in subcortical vascular dementia and Alzheimer's diseaseEUROPEAN NEUROPSYCHOPHARMACOLOGYIF6.72008-08-010PRE
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向